40 studies found for:    Open Studies | "Vitamin K"
Show Display Options
Rank Status Study
1 Recruiting Effect of Vitamin K Supplementation on Markers of Diabetes Risk in Obese Children
Conditions: Obesity;   Insulin Resistance;   Insulin Sensitivity;   Beta-Cell Dysfunction;   Prediabetes
Interventions: Dietary Supplement: Placebo-Control;   Dietary Supplement: Low-Dose Vitamin K2 (menaquinone-7; 45 mcg/d);   Dietary Supplement: High-Dose Vitamin K2 (menaquinone-7; 90 mcg/d)
2 Unknown  Vitamin K as Additive Treatment in Osteoporosis
Condition: Post-Menopausal Osteoporosis
Interventions: Drug: Phylloquinone;   Drug: Menaquinone (MK4);   Drug: placebo
3 Unknown  Investigation of the Effect of Vitamin K3-lotion for the Treatment of Cetuximab Induced Folliculitis
Condition: Folliculitis
Intervention: Other: Vitamin K3
4 Unknown  Vitamin K2 and Vessel Calcification in Chronic Kidney Disease Patients
Conditions: Kidney Diseases;   Coronary Artery Calcification
Interventions: Drug: Vitamin K2+10μg cholecalciferol;   Drug: Vitamin D
5 Recruiting Vitamin K to Attenuate Coronary Artery Calcification in Hemodialysis Patients
Condition: Endstage Kidney Disease
Interventions: Drug: Vitamin K1;   Drug: Chrystalline Lactose
6 Recruiting Vitamin K1 to Slow Progression of Vascular Calcification in HD Patients
Condition: Vitamin K1 to Slow the Progression of Thoracic Aortic and Coronary Artery Calcification
Intervention: Drug: Vitamin K1
7 Recruiting The Effects of Vitamin K2 Supplementation on the Progression of Coronary Artery Calcification
Condition: Coronary Artery Disease
Interventions: Dietary Supplement: Menaquinone-7 (Vitamin K2);   Other: Placebo capsules
8 Recruiting Vitamin K Supplement for Inhibition of the Progress in Aortic Valve Calcification
Condition: Aortic Valve Calcification
Intervention: Dietary Supplement: Vitamin K supplementation
9 Recruiting A Study Exploring Two Strategies of Rivaroxaban (JNJ39039039; BAY-59-7939) and One of Oral Vitamin K Antagonist in Patients With Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention
Conditions: Atrial Fibrillation;   Percutaneous Coronary Intervention
Interventions: Drug: rivaroxaban 2.5 mg;   Drug: rivaroxaban 15 mg;   Drug: rivaroxaban 10 mg;   Drug: aspirin (ASA);   Drug: vitamin K antagonist (VKA);   Drug: clopidogrel;   Drug: prasugrel;   Drug: ticagrelor
10 Not yet recruiting Phase II Randomized Placebo-controlled Study With Vitamin K2 in Asymptomatic Calcified Carotid Stenosis
Conditions: Carotid Disease;   Atherosclerosis
Intervention: Drug: Vitamin K2 (Menaquinone)
11 Unknown  Comparing Different Routes and Doses of Phytonadione (Vitamin K) for Reversing Warfarin Treated Patients With Hip Fracture Before Surgery
Conditions: Bleeding;   Complications
Intervention: Drug: Phytonadione
12 Not yet recruiting Apixaban During Atrial Fibrillation Catheter Ablation: Comparison to Vitamin K Antagonist Therapy
Condition: Atrial Fibrillation
Interventions: Drug: Vitamin K antagonist;   Drug: Apixaban
13 Recruiting A Study Exploring Two Treatment Strategies in Patients With Atrial Fibrillation Who Undergo Catheter Ablation Therapy
Condition: Atrial Fibrillation
Interventions: Drug: rivaroxaban;   Drug: uninterrupted vitamin K antagonist (VKA)
14 Recruiting Study Of The Blood Thinner, Apixaban, For Patients Who Have An Abnormal Heart Rhythm (Atrial Fibrillation) And Expected To Have Treatment To Put Them Back Into A Normal Heart Rhythm (Cardioversion)
Condition: Atrial Fibrillation
Interventions: Drug: Apixaban;   Drug: Parenteral heparin and/or oral Vitamin K antagonist
15 Recruiting Biomarkers and Antithrombotic Treatment in Cervical Artery Dissection - TREAT-CAD
Condition: Cervical Artery Dissection
Interventions: Drug: Acetylsalicylic acid;   Drug: vitamin K-antagonist
16 Recruiting Long-term Treatment for Cancer Patients With Deep Venous Thrombosis or Pulmonary Embolism
Conditions: Venous Thromboembolism;   Neoplasms
Interventions: Drug: low molecular weight heparin;   Drug: vitamin K antagonists
17 Unknown  Efficacy and Safety of the Prophylactic Use of Doxycycline +/- Vitamin K Cream
Condition: Metastatic Colorectal Cancer
Interventions: Device: Reconval K1 Cream;   Device: Reconval Cream
18 Recruiting Reversal Agent Use in Patients Treated With Direct Oral Anticoagulants or Vitamin K Antagonists
Conditions: Severe Bleeding;   Urgent Surgery
Intervention:
19 Unknown  Monitoring Anticoagulant Therapy in Antiphospholipid Syndrome
Condition: Antiphospholipid Syndrome
Intervention:
20 Recruiting Prospective Study on the Treatment of Unsuspected Pulmonary Embolism in Cancer Patients
Condition: Unsuspected Pulmonary Embolism
Intervention: Drug: Heparin, fondaparinux, vitamin-K antagonists, aspirin

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years